NCT06620835 2025-07-29
OPTALK
Groupe Francais De Pneumo-Cancerologie
Phase 2 Recruiting
Clinical Trials
7 trialsNCT05766046 2024-03-26
RISP
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Recruiting
NCT03645317 2021-08-02
ACCOLADE
The Christie NHS Foundation Trust
Phase NA Unknown
NCT02839681 2019-05-21
Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01604642 2018-04-02
Role of Activin A (ActA) in the Human Cancer Cachexia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase NA Completed
NCT01687647 2014-04-09
AMORCE-CBP
University Hospital, Caen
Phase 3 Unknown
NCT02090166 2014-03-18
EDLC
Carmel Medical Center
Phase NA Unknown